Granted Patent
B2
US 8,765,432 · App. 13/515,913 · Granted Jul 1, 2014
Targeted drug phosphorylcholine polymer conjugates
Assignee:
Oligasis, LLC
View Patent ↗
Loading inventors, assignments & file history…
Abstract
The present invention provides random copolymers containing phosphorylcholine and one or more functional agents, and methods of preparing such random copolymers.
Claims (3)
1. A random copolymer of Formula I:
wherein n and m are each independently from 1-1000.
2. A method of treating cancer, comprising administering an ameliorative amount of the random copolymer of claim 1 to a subject in need thereof, wherein the cancer is colon cancer, lung cancer, breast cancer, stomach cancer, ovarian cancer, or malignant melanoma.
Assignments (5)
RELEASE OF SECURITY INTEREST
Recorded Apr 15, 2019
From: BAKER BROS. ADVISORS LP
To: KODIAK SCIENCES INC.
Reel/Frame 048888/0927 →
CHANGE OF NAME
Recorded Feb 2, 2018
From: OLIGASIS, LLC
To: KODIAK SCIENCES INC.
Reel/Frame 045243/0924 →
SECURITY INTEREST
Recorded Aug 11, 2017
From: KODIAK SCIENCES INC.
To: BAKER BROS. ADVISORS LP
Reel/Frame 043272/0561 →
NUNC PRO TUNC ASSIGNMENT
Recorded May 1, 2014
From: CHARLES, STEPHEN A.; PERLROTH, D. VICTOR
To: OLIGASIS, LLC
Reel/Frame 032804/0970 →
ASSIGNMENT OF ASSIGNOR'S INTEREST
Recorded Aug 27, 2012
From: CHARLES, STEPHEN A.; PERLROTH, D. VICTOR
To: OLIGASIS
Reel/Frame 028855/0986 →
Continuity (2)
Provisional Application
61288127
· Dec 18, 2009